Longitudinal Effects of Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients and the Utility of Non-invasive Fibrosis Markers During Treatment: A single-center experience for up to 17 years

BACKGROUND: Fibrosis regression has been associated with nucleoside analog (NA) treatment in chronic hepatitis B (CHB) patients. Although non-invasive fibrosis markers have been evaluated in CHB, their utility for monitoring on-treatment histologic regression has not been evaluated. AIMS: To charact...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antiviral Res
Auteurs principaux: Surana, Pallavi, Kapuria, Devika, Broadwell, Carly, Wright, Elizabeth C., Takyar, Varun, Kleiner, David E., Ghany, Marc G., Ben-Yakov, Gil, Heller, Theo, Liang, T. Jake, Koh, Christopher
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620142/
https://ncbi.nlm.nih.gov/pubmed/31125632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2019.05.007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires